Evolus, Inc. (EOLS)
4.365
-0.06
(-1.24%)
USD |
NASDAQ |
Feb 20, 16:00
4.365
0.00 (0.00%)
After-Hours: 19:06
Evolus EPS Diluted (Quarterly) : -0.2431 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.74M |
| Revenue (Quarterly) | 68.97M |
| Total Expenses (Quarterly) | 84.70M |
| Enterprise Value | 397.87M |
| Gross Profit Margin (Quarterly) | 64.81% |
| Profit Margin (Quarterly) | -22.82% |
| Earnings Yield | -20.90% |
| Normalized Earnings Yield | -20.61 |